Mov Disord Vol 38, Suppl 1 Archives - Page 71 of 186 - MDS Abstracts

2023 International Congress
A pilot study to prepare patients for doctor’s consultation based on the NMS-Quest and a wearable medical device
L. Carrasco, D. álvarez, M. Pérez, C. Capra, D. Rodriguez-Martin, M. Mata, M. Kurtis, C. Borrué, L. López-Manzanares (Madrid, Spain)
Objective: To evaluate the feasibility of a consultation preparation service (CPS) for Parkinson's Disease patients and its effect on the patients’ experience during consultation. Background:…
2023 International Congress
Emergent alpha-beta oscillations are accompanied with worsening motor symptoms in Parkinson’s disease
E. Belova, U. Semenova, A. Gamaleya, A. Tomskiy, A. Sedov (Moscow, Russian Federation)
Objective: The aim of the study was to imply observer-independent approach to search for the ranges of stable oscillations in broad alpha-beta range inside the…
2023 International Congress
Comparing Change in Motor and ADL Rating Scales after DBS in Parkinson’s disease, Dystonia and Tremor
Y. Wiggerts, E. Markidis, A. Weide, M. Bot, V. Odekerken, P. Munckhof, J. Dijk, Y. Namavar, R. Schuurman, R. Bie, M. Beudel (Amsterdam, Netherlands)
Objective: To assess the relationship between deep brain stimulation (DBS)-induced improvements on motor symptoms and activities of daily living (ADL) in a single-center cohort of…
2023 International Congress
Analysis of excessive daytime sleepiness and clinical findings in Parkinson’s disease
S. Ueno, N. Nishikawa, H. Takeshige-Amano, T. Ogawa, D. Kamiyama, A. Shindo, K. Shiina, K. Ishikawa, T. Tsunemi, M. Yoshitake, C. Abe, S. Saiki, T. Hatano, N. Hattori (Tokyo, Japan)
Objective: To explore clinical biomarkers associated with excessive daytime sleepiness (EDS) using a real-world cohort database of Parkinson’s disease (PD). Background: Although evidence for current…
2023 International Congress
Deep brain stimulation modulates subthalamic beta bursts related to movement velocity adjustments in Parkinson’s disease
M. Bange, G. Gonzalez-Escamilla, DM. Herz, G. Tinkhauser, M. Glaser, D. Ciolac, H. Tan, P. Brown, S. Groppa (Mainz, Germany)
Objective: The aim of this study was to investigate the role of subthalamic beta bursts for dynamic control of precise drawing movements. Background: The performance…
2023 International Congress
Slow progressive neurocognitive impairment with Parkinsonism: A rare, adult-onset Neuronal Intranuclear Inclusion disease (NIID) case report
AS. Mawardi, AA. Ab Ghapar, NH. Rahim, J. Joseph (Kuala Lumpur, Malaysia)
Objective: We described a case of a 62-years old lady with underlying diabetes and hypertension, presented with right upper intermittent resting tremor and stiffness for…
2023 International Congress
Unsupervised multimodal digital assessment of fatigue and sleep disorders in Parkinson’s disease: the IDEA-FAST study
A. Pilotto, J. Kudelka, L. Correia, E. Lirani-Silva, J. Jimenez Ramos, S. Labrecque, R. Romijnders, C. Hansen, C. Maetzler, A. Rizzardi, C. Zatti, U. Funken, W. Remmele, A. Santos, S. Del Din, L. Rochester, J. Ferreira, A. Padovani, A. Yarnall, K. Seppi, F. Ng, W. Maetzler (Brescia, Italy)
Objective: To evaluate fatigue and sleep disorders in unsupervised conditions in neurodegenerative and autoimmune conditions using a combination of mobility, autonomic and sleep digital home…
2023 International Congress
Stepwise Dual-Target MR-guided Focused Ultrasound in A Patient with Advanced Parkinson’s Disease
CH. Tsai, MK. Lu, JC. Chen, CM. Chen (Taichung, Taiwan)
Objective: To illustrate a successful stepwise dual target MRI guided focused ultrasound ablation in a patient with advanced Parkinson's disease (PD). Background: MR-guided focused ultrasound…
2023 International Congress
Improvement in motor symptoms and quality of life in patients with an earlier stage of advanced Parkinson’s disease treated with foslevodopa/foscarbidopa subcutaneous 24 hour infusion
A. Antonini, B. Bergmans, D. Kern, P. Odin, L. Bergmann, R. Gupta, J. Homola, M. Shah, J. Zamudio, D. Standaert (Padova, Italy)
Objective: To evaluate whether treatment with foslevodopa/foscarbidopa (LDP/CDP), a continuous (24‑hour/day) subcutaneous infusion of carbidopa/levodopa prodrugs, improves motor fluctuations and quality of life (QoL) in…
2023 International Congress
Parkinson’s Disease Hospital Optimization Project
B. Valdovinos, K. Amodeo, E. Kanouse, A. Chesire, J. Lowell, M. Braun, N. Chunga, D. Ruebeck, A. Macikowski, V. Basic, M. Deweese, E. Hufziger, J. Hayes, A. Skuse, I. Richard (Rochester, USA)
Objective: To describe The Parkinson’s Disease Hospital Optimization Project (PD-HOP) that we established to optimize inpatient care and improve the hospital experience and outcomes for…